trending Market Intelligence /marketintelligence/en/news-insights/trending/ob8pwmnk3grbw5d2bs2foq2 content esgSubNav
In This List

Verastem Oncology begins $35M common stock offering

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Verastem Oncology begins $35M common stock offering

Verastem Inc. commenced a public offering of its common stock worth $35 million.

The Needham, Mass.-based biopharmaceutical company granted the underwriter an option to buy up to an additional $5.25 million worth of common shares.

Cantor Fitzgerald & Co. is acting as sole book-running manager for the offering.